CLUSTER filed Sep 9, 2026 at 16:02 ET
A cluster of insider selling at Artiva Biotherapeutics (ARTV) totaling $477K over the past week, led by CEO Fred Aslan ($256K open-market sale) and joined by the COO, CTO, and CMO. The selling is modest relative to the $500M market cap (~0.1%), and the cluster is dominated by open-market sales from C-suite executives, which per academic literature are weak predictors of future returns. The net signal is neutral-to-slightly-bearish given the CEO's open-market sale, but the dollar amount is below the materiality threshold for a strong bearish call.